Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Jinjin Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in the production of steroid hormones and Vitamin D derivatives. As a core subsidiary of the Tianjin Pharmaceutical Group, the company has established itself as one of the world's largest production bases for dexamethasone and its related derivatives. Their business model focuses on the large-scale synthesis of Active Pharmaceutical Ingredients (APIs) and the manufacturing of finished dosage forms for global markets. The company's facilities are GMP-certified, and many of its products hold international certifications such as CEP/COS, enabling export to Europe, North America, and Southeast Asia. Jinjin Pharmaceutical plays a critical role in the global supply chain for essential corticosteroids and mineralocorticoid antagonists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Jinjin Pharmaceutical.